AzTrials
AzTrials

ObesityCafeteriaNCT00573482

A Cafeteria Based Study of Weight Gain Prevention

A study testing REDE in people with Obesity and Overweight, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The dramatic rise in overweight and obesity during the past several decades can be explained by environmental changes that foster increased energy intake and decreased energy expenditure. Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Obesity, Overweight
What is being tested?
REDE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
106 participants
Where
1 siteUnited States
Study dates
Sep 2002to Feb 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • works at one of the two hospitals and eats lunch in the cafeteria 2x per week
  • BMI between 23 and 25

Who cannot join

  • current diagnosis of a chronic disease or condition known to affect appetite or body weight
  • currently taking medication known to affect appetite or body weight
  • current pregnancy or plans to become pregnant within the next 24 months
  • current enrollment or plans to enroll within the next 24 months in an organized weight management program
  • plans to terminate employment at the hospital within the next 12 months

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Local Hospitals

    Philadelphia, Pennsylvania

Other trials in United States

About this study

The dramatic rise in overweight and obesity during the past several decades can be explained by environmental changes that foster increased energy intake and decreased energy expenditure. There are several reasons to suggest that the most effective approach to weight gain prevention is the incorporate reduced-fat eating into an overall strategy of lowering the energy density of the diet. Our energy density manipulations will be designed to reduce both the fat content and the caloric density of foods served at a cafeteria, which serves as the "food environment" for hospital employees.

Conditions
Obesity, Overweight
Being tested
REDE, control
Keywords
weight gain prevention, obesity, overweight, food environment, The intervention group received the education in REDE techniques, The control group received no intervention at all., Both groups were exposed to the food labels and the new lower ED foods., Only the intervention group received the education sessions and only they were eligible for the price reductions.
Medical subject headings
Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • REDEBehavioural

    The intervention group received the education in REDE techniques.

    The intervention in this study comprised four components:

    • Four group education sessions to introduce the REDE principles of eating;
    • Approximately 10 new lower energy-dense foods were introduced in the employee cafeteria daily at lunchtime;
    • Food labels for all foods sold in the employee cafeteria at lunch time, which provided the energy density, calories, and macronutrient content of the prepared cafeteria foods. Prior to the intervention almost no foods had food labels.
    • Price reductions for lower energy density items. Both groups were exposed to the food labels and the new lower ED foods, but only the intervention group received the education sessions about how to take advantage of the new labels and cafeteria foods and only they were eligible for the price reductions.
  • controlBehavioural

    The control group received no REDE intervention at all. Both groups were exposed to the food labels and the new lower ED foods, but the control group did not receive the education sessions.

Study groups in NCT00573482
Study groupRoleWhat they receive
control groupActive comparatorControl (only exposure to the food labels and the new lower ED foods).
Receives: Behavioral: control
intervention groupExperimentalEducation in REDE techniques plus exposure to the food labels and the new lower ED foods.
Receives: Behavioral: REDE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight

    Measured: 36 months

Secondary outcomes (1)
  1. Caloric and macro-nutrient intake

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2007 (estimated)
  2. Study startSep 2002
  3. Study completionFeb 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00573482
Sponsor's protocol ID
DK02-021 (completed)
Other IDs
5R01HL073775
Acronym
Cafeteria
Status last verified
Feb 2010
First submitted
12 Dec 2007
Last updated
25 Feb 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing REDE in people with Obesity and Overweight, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in